DRL launches Fenofibrate capsules, USP 43 mg and 130 mg
Dr Reddy’s Laboratories (DRL) has launched Fenofibrate capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin inks joint venture agreement with Yoshindo
New entity YL Biologics to focus on clinical development and commercialisation of biosimilars for Japan
Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
US FDA approves Cyramza for stomach cancer
Cyramza is an angiogenesis inhibitor that blocks the blood supply to tumours
April 16-30, 2014
{source}<div data-configid="5690019/7546900" style="width: 600px; height: 389px;" class="issuuembed"></div><script…
UBM India to organise 3rd Annual Global Pharma Regulatory Summit 2014
Event to be held in Mumbai from April 23 to 25, 2014
Anders Malm appointed as Managing Director at Ecron Acunova
Malm will assume the responsibility for operations of Europe and North America
C-Suite Executives in India & APAC foresee the advent of SIOs as critical success factor in…
Survey conducted amongst 326 C-suite executive across India & APAC region
The Path: Improving the process of improvement
To achieve sustainable growth amidst increasingly complex and chaotic business environment, an organisation must figure out its…